DTHR — Dthera Sciences Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for Dthera Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2013 July 31st	2014 July 31st	2015 June 30th	2016 June 30th	2017 December 31st
Period Length:	7 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-0.004	-0.022	-0.379	-0.231	-2.56
Depreciation
Non-Cash Items	—	—	0.079	0	0.364
Unusual Items
Other Non-Cash Items
Changes in Working Capital	0	-0.022	0.04	0.158	0.059
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-0.004	-0.045	-0.261	-0.073	-2.13
Capital Expenditures	—	—	—	—	-0.078
Purchase of Fixed Assets
Other Investing Cash Flow Items	—	—	-0.075	0	—
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	—	—	-0.075	0	-0.078
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	0.004	0.054	-0.075	0.038	2.52
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	0	0.009	-0.411	-0.035	0.311